Kure Advisory Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Core Equity Market ETF
DFAU
|
+$2.13M |
| 2 |
Vanguard Morningstar Growth ETF
VUG
|
+$2.06M |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$1.75M |
| 4 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.06M |
| 5 |
Innovator Defined Wealth Shield ETF
BALT
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BP
BP
|
+$241K |
| 2 |
Chevron
CVX
|
+$236K |
| 3 |
Phillips 66
PSX
|
+$213K |
| 4 |
Medtronic
MDT
|
+$204K |
| 5 |
ConocoPhillips
COP
|
+$203K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.87% |
| 2 | Technology | 3.03% |
| 3 | Financials | 0.98% |
| 4 | Industrials | 0.74% |
| 5 | Consumer Staples | 0.65% |
No holdings matched the selected filter criteria.
Similar funds
Kure Advisory's Q2 2026 Portfolio in Review
As of Q2 2026, Kure Advisory held 67 positions worth $211M, up 15% from $184M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Kure Advisory deployed $13.6M of net new capital in Q2 2026, opening 11 new positions and adding to 28 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 1,902 shares worth $432K.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Broadcom, an estimated $128K trimmed.
- Kure Advisory's largest Q2 2026 buy was iShares S&P 500 Value ETF: 1,902 shares worth $432K.
- Kure Advisory added most to Dimensional US Core Equity Market ETF in Q2 2026, an estimated $2.13M increase.
- Kure Advisory's biggest Q2 2026 reduction was Broadcom, cutting an estimated $128K.
- Kure Advisory fully exited BP in Q2 2026, selling an estimated $241K.
- Kure Advisory's ten largest holdings make up 79% of its $211M portfolio in Q2 2026.
- Kure Advisory opened 11 new positions and closed 5 in Q2 2026.
- Kure Advisory's portfolio value rose 15% quarter-over-quarter to $211M.
Based on Kure Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.